Latest Insider Transactions at Myriad Genetics Inc (MYGN)
This section provides a real-time view of insider transactions for Myriad Genetics Inc (MYGN). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of MYRIAD GENETICS INC to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of MYRIAD GENETICS INC's insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jun 05
2025
|
Colleen F Reitan Director |
BUY
Grant, award, or other acquisition
|
Direct |
49,796
+35.04%
|
-
|
|
Jun 05
2025
|
Lee Nisley Newcomer Director |
BUY
Grant, award, or other acquisition
|
Direct |
49,796
+27.37%
|
-
|
|
Jun 05
2025
|
S. Louise Phanstiel Director |
BUY
Grant, award, or other acquisition
|
Direct |
49,796
+21.91%
|
-
|
|
Jun 05
2025
|
Mark Steven Davis Director |
BUY
Grant, award, or other acquisition
|
Direct |
24,148
+33.96%
|
-
|
|
Jun 05
2025
|
Paul Bisaro Director |
BUY
Grant, award, or other acquisition
|
Direct |
49,796
+35.64%
|
-
|
|
Jun 05
2025
|
Heinrich Dreismann Director |
BUY
Grant, award, or other acquisition
|
Direct |
49,796
+22.51%
|
-
|
|
Jun 05
2025
|
Daniel Skovronsky Director |
BUY
Grant, award, or other acquisition
|
Direct |
49,796
+26.83%
|
-
|
|
Jun 05
2025
|
Rashmi Kumar Director |
BUY
Grant, award, or other acquisition
|
Direct |
49,796
+28.14%
|
-
|
|
May 31
2025
|
Samraat S. Raha President and CEO |
BUY
Grant, award, or other acquisition
|
Direct |
1,498
+0.31%
|
$4,494
$3.56 P/Share
|
|
May 01
2025
|
Brian J Donnelly Chief Commerical Officer |
BUY
Grant, award, or other acquisition
|
Direct |
397,534
+37.15%
|
-
|
|
Apr 14
2025
|
Mark Verratti Chief Operating Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,085
-0.28%
|
$8,680
$8.08 P/Share
|
|
Apr 14
2025
|
Dale Muzzey Chief Scientific Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
942
-0.55%
|
$7,536
$8.08 P/Share
|
|
Mar 25
2025
|
Natalie Munk Chief Accounting Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
362
-0.78%
|
$3,258
$9.73 P/Share
|
|
Mar 24
2025
|
Paul J Diaz President and CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
45,139
-2.44%
|
$406,251
$9.98 P/Share
|
|
Mar 24
2025
|
Mark Verratti Chief Operating Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
2,701
-0.35%
|
$24,309
$9.98 P/Share
|
|
Mar 24
2025
|
Dale Muzzey Chief Scientific Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,345
-0.39%
|
$12,105
$9.98 P/Share
|
|
Mar 24
2025
|
Kevin Richard Haas Chief Technology Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
2,901
-0.8%
|
$26,109
$9.98 P/Share
|
|
Mar 24
2025
|
Natalie Munk Chief Accounting Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
982
-1.04%
|
$8,838
$9.98 P/Share
|
|
Mar 22
2025
|
Paul J Diaz President and CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
72,541
-3.65%
|
$725,410
$10.01 P/Share
|
|
Mar 22
2025
|
Mark Verratti Chief Operating Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
4,989
-0.64%
|
$49,890
$10.01 P/Share
|
|
Mar 22
2025
|
Dale Muzzey Chief Scientific Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
7,345
-2.05%
|
$73,450
$10.01 P/Share
|
|
Mar 22
2025
|
Kevin Richard Haas Chief Technology Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
6,187
-1.66%
|
$61,870
$10.01 P/Share
|
|
Mar 22
2025
|
Natalie Munk Chief Accounting Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,563
-1.6%
|
$15,630
$10.01 P/Share
|
|
Mar 22
2025
|
Margaret Ancona SVP, Chief of Staff |
SELL
Payment of exercise price or tax liability
|
Direct |
2,622
-1.0%
|
$26,220
$10.01 P/Share
|
|
Mar 15
2025
|
Dale Muzzey Chief Scientific Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
4,764
-2.58%
|
$47,640
$10.07 P/Share
|
|
Mar 15
2025
|
Kevin Richard Haas Chief Technology Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
3,335
-1.75%
|
$33,350
$10.07 P/Share
|
|
Mar 15
2025
|
Margaret Ancona SVP, Chief of Staff |
SELL
Payment of exercise price or tax liability
|
Direct |
1,572
-1.18%
|
$15,720
$10.07 P/Share
|
|
Mar 15
2025
|
Natalie Munk Chief Accounting Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
684
-1.38%
|
$6,840
$10.07 P/Share
|
|
Mar 15
2025
|
Paul J Diaz President and CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
30,118
-2.9%
|
$301,180
$10.07 P/Share
|
|
Mar 15
2025
|
Mark Verratti Chief Operating Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
3,729
-0.94%
|
$37,290
$10.07 P/Share
|
|
Mar 14
2025
|
Dale Muzzey Chief Scientific Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
8,544
-4.41%
|
$85,440
$10.07 P/Share
|
|
Mar 14
2025
|
Kevin Richard Haas Chief Technology Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
4,390
-2.25%
|
$43,900
$10.07 P/Share
|
|
Mar 14
2025
|
Shereen Solaiman Chief People Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
6,060
-5.18%
|
$60,600
$10.07 P/Share
|
|
Mar 14
2025
|
Margaret Ancona SVP, Chief of Staff |
SELL
Payment of exercise price or tax liability
|
Direct |
3,417
-2.51%
|
$34,170
$10.07 P/Share
|
|
Mar 14
2025
|
Natalie Munk Chief Accounting Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
855
-1.69%
|
$8,550
$10.07 P/Share
|
|
Mar 14
2025
|
Paul J Diaz President and CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
37,564
-3.49%
|
$375,640
$10.07 P/Share
|
|
Mar 14
2025
|
Samraat S. Raha President and CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
7,649
-1.56%
|
$76,490
$10.07 P/Share
|
|
Mar 14
2025
|
Scott J. Leffler Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
6,217
-2.77%
|
$62,170
$10.07 P/Share
|
|
Mar 14
2025
|
Mark Verratti Chief Operating Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
5,847
-1.46%
|
$58,470
$10.07 P/Share
|
|
Mar 13
2025
|
Jennifer Lynne Fox Chief Legal Officer |
BUY
Grant, award, or other acquisition
|
Direct |
63,145
+33.58%
|
-
|
|
Mar 13
2025
|
Dale Muzzey Chief Scientific Officer |
BUY
Grant, award, or other acquisition
|
Direct |
75,773
+28.14%
|
-
|
|
Mar 13
2025
|
Kevin Richard Haas Chief Technology Officer |
BUY
Grant, award, or other acquisition
|
Direct |
54,124
+21.69%
|
-
|
|
Mar 13
2025
|
Shereen Solaiman Chief People Officer |
BUY
Grant, award, or other acquisition
|
Direct |
63,145
+35.05%
|
-
|
|
Mar 13
2025
|
Margaret Ancona SVP, Chief of Staff |
BUY
Grant, award, or other acquisition
|
Direct |
54,124
+28.42%
|
-
|
|
Mar 13
2025
|
Natalie Munk Chief Accounting Officer |
BUY
Grant, award, or other acquisition
|
Direct |
4,000
+7.33%
|
-
|
|
Mar 13
2025
|
Samraat S. Raha President and CEO |
BUY
Grant, award, or other acquisition
|
Direct |
216,495
+30.69%
|
-
|
|
Mar 13
2025
|
Scott J. Leffler Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
72,165
+24.32%
|
-
|
|
Mar 13
2025
|
Mark Verratti Chief Operating Officer |
BUY
Grant, award, or other acquisition
|
Direct |
99,227
+19.83%
|
-
|
|
Mar 01
2025
|
Shereen Solaiman Chief People Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,912
-3.43%
|
$19,120
$10.73 P/Share
|
|
Feb 25
2025
|
Margaret Ancona SVP, Chief of Staff |
SELL
Payment of exercise price or tax liability
|
Direct |
2,697
-3.44%
|
$29,667
$11.74 P/Share
|